Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy

Salma I. Patel, Chad Cherington, Robyn Scherber, Kathryn Barr, Ryan McLemore, Donald E. Morisky, Stephen Cha, Farouk Mookadam, Fadi Shamoun

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Context: Direct oral anticoagulants (DOACs) may be as effective as, and at times safer than, warfarin. Because DOACs do not require regular serum level monitoring, patients’ interaction with the health care system may be reduced. To the authors’ knowledge, although studies have evaluated warfarin adherence, few studies have evaluated the real-world adherence to DOACs. Objective: To evaluate whether a difference exists between medication adherence of patients taking DOACs vs patients taking warfarin. Methods: The electronic medical records of the Anticoagulation Clinic database at Mayo Clinic in Scottsdale, Arizona, were reviewed. Inclusion criteria were adults taking DOACs and a matching cohort taking warfarin between January 1, 2011, and December 30, 2013. The Morisky Medication Adherence Scale-8 item, a validated medication adherence tool, was used to evaluate adherence in both cohorts, and the qualitative covariates were analyzed using ordinal logistic regression. Results: Of 324 surveys that were sent, 110 patients (34.0%) responded. Most patients took DOACs for atrial fibrillation, and few took DOACs for venous thromboembolism. Overall, 60 of 66 patients (90.9%) in the DOAC group and 42 of 44 patients (95.5%) in the warfarin group reported medium or high adherence. Difference in adherence scores between the 2 groups was not statistically significant (P=.8). Conclusion: Similar adherence was noted between DOACs and warfarin regardless of the frequency of serum level monitoring.

Original languageEnglish (US)
Pages (from-to)7-15
Number of pages9
JournalJournal of the American Osteopathic Association
Volume117
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Warfarin
Patient Compliance
Anticoagulants
Medication Adherence
Therapeutics
Electronic Health Records
Venous Thromboembolism
Physiologic Monitoring
Serum
Atrial Fibrillation
Logistic Models
Databases
Delivery of Health Care

Keywords

  • Apixaban
  • Dabigatran
  • Directoral anticoagulants
  • Medication adherence
  • Rivaroxaban
  • Warfarin

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Patel, S. I., Cherington, C., Scherber, R., Barr, K., McLemore, R., Morisky, D. E., ... Shamoun, F. (2017). Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy. Journal of the American Osteopathic Association, 117(1), 7-15. https://doi.org/10.7556/jaoa.2017.002

Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy. / Patel, Salma I.; Cherington, Chad; Scherber, Robyn; Barr, Kathryn; McLemore, Ryan; Morisky, Donald E.; Cha, Stephen; Mookadam, Farouk; Shamoun, Fadi.

In: Journal of the American Osteopathic Association, Vol. 117, No. 1, 01.01.2017, p. 7-15.

Research output: Contribution to journalArticle

Patel, SI, Cherington, C, Scherber, R, Barr, K, McLemore, R, Morisky, DE, Cha, S, Mookadam, F & Shamoun, F 2017, 'Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy', Journal of the American Osteopathic Association, vol. 117, no. 1, pp. 7-15. https://doi.org/10.7556/jaoa.2017.002
Patel, Salma I. ; Cherington, Chad ; Scherber, Robyn ; Barr, Kathryn ; McLemore, Ryan ; Morisky, Donald E. ; Cha, Stephen ; Mookadam, Farouk ; Shamoun, Fadi. / Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy. In: Journal of the American Osteopathic Association. 2017 ; Vol. 117, No. 1. pp. 7-15.
@article{0dc58b73b1cc4fffaec7a4ab95ff86b6,
title = "Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy",
abstract = "Context: Direct oral anticoagulants (DOACs) may be as effective as, and at times safer than, warfarin. Because DOACs do not require regular serum level monitoring, patients’ interaction with the health care system may be reduced. To the authors’ knowledge, although studies have evaluated warfarin adherence, few studies have evaluated the real-world adherence to DOACs. Objective: To evaluate whether a difference exists between medication adherence of patients taking DOACs vs patients taking warfarin. Methods: The electronic medical records of the Anticoagulation Clinic database at Mayo Clinic in Scottsdale, Arizona, were reviewed. Inclusion criteria were adults taking DOACs and a matching cohort taking warfarin between January 1, 2011, and December 30, 2013. The Morisky Medication Adherence Scale-8 item, a validated medication adherence tool, was used to evaluate adherence in both cohorts, and the qualitative covariates were analyzed using ordinal logistic regression. Results: Of 324 surveys that were sent, 110 patients (34.0{\%}) responded. Most patients took DOACs for atrial fibrillation, and few took DOACs for venous thromboembolism. Overall, 60 of 66 patients (90.9{\%}) in the DOAC group and 42 of 44 patients (95.5{\%}) in the warfarin group reported medium or high adherence. Difference in adherence scores between the 2 groups was not statistically significant (P=.8). Conclusion: Similar adherence was noted between DOACs and warfarin regardless of the frequency of serum level monitoring.",
keywords = "Apixaban, Dabigatran, Directoral anticoagulants, Medication adherence, Rivaroxaban, Warfarin",
author = "Patel, {Salma I.} and Chad Cherington and Robyn Scherber and Kathryn Barr and Ryan McLemore and Morisky, {Donald E.} and Stephen Cha and Farouk Mookadam and Fadi Shamoun",
year = "2017",
month = "1",
day = "1",
doi = "10.7556/jaoa.2017.002",
language = "English (US)",
volume = "117",
pages = "7--15",
journal = "The Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "1",

}

TY - JOUR

T1 - Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy

AU - Patel, Salma I.

AU - Cherington, Chad

AU - Scherber, Robyn

AU - Barr, Kathryn

AU - McLemore, Ryan

AU - Morisky, Donald E.

AU - Cha, Stephen

AU - Mookadam, Farouk

AU - Shamoun, Fadi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Context: Direct oral anticoagulants (DOACs) may be as effective as, and at times safer than, warfarin. Because DOACs do not require regular serum level monitoring, patients’ interaction with the health care system may be reduced. To the authors’ knowledge, although studies have evaluated warfarin adherence, few studies have evaluated the real-world adherence to DOACs. Objective: To evaluate whether a difference exists between medication adherence of patients taking DOACs vs patients taking warfarin. Methods: The electronic medical records of the Anticoagulation Clinic database at Mayo Clinic in Scottsdale, Arizona, were reviewed. Inclusion criteria were adults taking DOACs and a matching cohort taking warfarin between January 1, 2011, and December 30, 2013. The Morisky Medication Adherence Scale-8 item, a validated medication adherence tool, was used to evaluate adherence in both cohorts, and the qualitative covariates were analyzed using ordinal logistic regression. Results: Of 324 surveys that were sent, 110 patients (34.0%) responded. Most patients took DOACs for atrial fibrillation, and few took DOACs for venous thromboembolism. Overall, 60 of 66 patients (90.9%) in the DOAC group and 42 of 44 patients (95.5%) in the warfarin group reported medium or high adherence. Difference in adherence scores between the 2 groups was not statistically significant (P=.8). Conclusion: Similar adherence was noted between DOACs and warfarin regardless of the frequency of serum level monitoring.

AB - Context: Direct oral anticoagulants (DOACs) may be as effective as, and at times safer than, warfarin. Because DOACs do not require regular serum level monitoring, patients’ interaction with the health care system may be reduced. To the authors’ knowledge, although studies have evaluated warfarin adherence, few studies have evaluated the real-world adherence to DOACs. Objective: To evaluate whether a difference exists between medication adherence of patients taking DOACs vs patients taking warfarin. Methods: The electronic medical records of the Anticoagulation Clinic database at Mayo Clinic in Scottsdale, Arizona, were reviewed. Inclusion criteria were adults taking DOACs and a matching cohort taking warfarin between January 1, 2011, and December 30, 2013. The Morisky Medication Adherence Scale-8 item, a validated medication adherence tool, was used to evaluate adherence in both cohorts, and the qualitative covariates were analyzed using ordinal logistic regression. Results: Of 324 surveys that were sent, 110 patients (34.0%) responded. Most patients took DOACs for atrial fibrillation, and few took DOACs for venous thromboembolism. Overall, 60 of 66 patients (90.9%) in the DOAC group and 42 of 44 patients (95.5%) in the warfarin group reported medium or high adherence. Difference in adherence scores between the 2 groups was not statistically significant (P=.8). Conclusion: Similar adherence was noted between DOACs and warfarin regardless of the frequency of serum level monitoring.

KW - Apixaban

KW - Dabigatran

KW - Directoral anticoagulants

KW - Medication adherence

KW - Rivaroxaban

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=85008462912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008462912&partnerID=8YFLogxK

U2 - 10.7556/jaoa.2017.002

DO - 10.7556/jaoa.2017.002

M3 - Article

C2 - 28055097

AN - SCOPUS:85008462912

VL - 117

SP - 7

EP - 15

JO - The Journal of the American Osteopathic Association

JF - The Journal of the American Osteopathic Association

SN - 0098-6151

IS - 1

ER -